<DOC>
	<DOCNO>NCT01170728</DOCNO>
	<brief_summary>This study multi-center study assess efficacy safety suture fixation Virtue® Male Sling .</brief_summary>
	<brief_title>Virtue® Male Sling Fixation Study</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>Male subject least 18 year age estimate life expectancy 5 year The subject confirm stress urinary incontinence ( SUI ) medical history , urodynamics , and/or physical exam least 6 month The subject complete postvoid residual per protocol within 6 week prior implant The subject complete cystoscopy per protocol within 12 month prior implant The subject intrinsic sphincter deficiency due one following : posttransurethral resection prostate ( TURP ) , simple open prostatectomy , radical prostatectomy complete least 6 month prior implantation date The subject fail least two noninvasive therapy , eg . pelvic/Kegel exercise , behavioral modification biofeedback least 6 month The subject willing Virtue® Male Sling implant The subject able willing complete followup visit procedure indicate protocol The subject inform nature study agree provision provide write informed consent approve local ethic committee respective site The subject unable unwilling sign inform consent form ( ICF ) and/or comply followup requirement accord study protocol The subject active urinary tract infection active skin infection region surgery The subject serious bleeding disorder The subject incontinence due neurogenic cause define multiple sclerosis , spinal cord/brain injury , cerebrovascular accident ( CVA ) , detrusorexternal sphincter dyssynergia , Parkinson 's disease , similar condition The subject previous implant treat stress urinary incontinence The subject undergone radiation , cryosurgery , brachy therapy treat prostate pelvic cancer within 6 month The subject likely undergo radiation therapy within next 6 month The subject active urethral bladder neck stricture disease require continue treatment The subject urge predominant incontinence The subject atonic bladder postvoid residual ( PVR ) great equal 150 milliliter ( mL ) The subject condition disorder likely require future transurethral procedure The subject enrol concurrent clinical study treatment ( drug device ) could affect continence function without sponsor 's approval The subject deem unfit male sling implantation participation research protocol determine attend physician</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Male Sling</keyword>
	<keyword>Fixation</keyword>
	<keyword>Stress Urinary Incontinence</keyword>
	<keyword>Urinary incontinence</keyword>
</DOC>